Excitatory amino acid transporters (EAATs) regulate glutamate concentrations in the brain to maintain normal excitatory synaptic transmission. A widely accepted view of transporters is that they consist of a pore with alternating access to the intracellular and extracellular solutions, which serves to couple ion movement to the movement of substrate. However, recent observations that EAATs, and also a number of other neurotransmitter transporters, can also function as ligand-gated chloride channels have blurred the distinctions between transporters and ion channels. Here we show that mutations in the second transmembrane domain (TM2) of EAAT1 alter anion permeation properties without affecting glutamate transport and that a number of TM2 residues are accessible to the external aqueous solution. Furthermore, we demonstrate that the extracellular edge of TM2 is in close proximity to a membrane-associated domain that influences glutamate transport. This study will provide the foundation for beginning to understand how transporters can function as both transporters and ion channels.In the mammalian central nervous system, glutamate is the predominant excitatory neurotransmitter, and EAATs 1 regulate synaptic glutamate concentrations to maintain a dynamic signaling process between neurons. EAATs are secondary active transporters in which glutamate is co-transported with 3 Na ϩ and 1 H ϩ followed by the counter-transport of 1 K ϩ (1), which enables EAATs to maintain a 10 6 -fold glutamate concentration gradient across the cell membrane. In addition to this coupled transport conductance, glutamate also activates a thermodynamically uncoupled chloride conductance through the transporter (2-4), which may serve a number of functions such as modulation of cell excitability, regulation of the rate of voltage-dependent glutamate uptake, and influencing ion homeostasis (4 -7). A number of other neurotransmitter transporters, including transporters for dopamine, serotonin, noradrenaline, and ␥-aminobutyric acid, also allow uncoupled fluxes of ions (8 -11), and in the case of the dopamine transporter the substrate-activated chloride conductance regulates presynaptic excitability (8). At present there is very little understanding of the molecular basis for how transporters can support these separate functions.Five EAAT subtypes have been characterized (3,(12)(13)(14)(15)(16), and the highly conserved carboxyl-terminal half of EAATs has been identified, by the use of chimeric transporters and site-directed mutagenesis, as forming the glutamate binding and/or translocation domain (17-23) (see Fig. 1A). However, a number of mutations that disrupt transport do not affect chloride permeation (for example see Refs. 18 and 24), and several recent studies have reported selective modulation of the transport component without affecting the chloride component of transport (20 -22), implying there are separate molecular determinants for glutamate transport and chloride permeation. In order to investigate this idea further, it is necessary t...
SUMMARYWe have investigated the mechanism of action of a series of glutamate derivatives on the cloned excitatory amino acid transporters 1 and 2 (EAAT1 and EAAT2), expressed in Xenopus laevis oocytes. The compounds were tested as substrates and competitive blockers of the glutamate transporters. A number of compounds showed contrasting mechanisms of action on EAAT1 compared with EAAT2. In particular, (2S,4R)-4-methylglutamate and 4-methylene-glutamate were transported by EAAT1, with K m values of 54 M and 391 M, respectively, but potently blocked glutamate transport by EAAT2, with K b values of 3.4 M and 39 M, respectively. Indeed, (2S,4R)-4-methylglutamate is the most potent blocker of EAAT2 yet described. (Ϯ)-Threo-3-methylglutamate also potently blocked glutamate transport by EAAT2 (K b ϭ 18 M), but was inactive on EAAT1 as either a substrate or a blocker at concentrations up to 300 M. In contrast to (2S,4R)-4-methylglutamate, L-threo-4-hydroxyglutamate was a substrate for both EAAT1 and EAAT2, with K m values of 61 M and 48 M, respectively. It seems that the chemical nature and also the orientation of the group at the 4-position of the carbon backbone of glutamate is crucial in determining the pharmacological activity. The conformations of these molecules have been modeled to understand the structural differences between, firstly, compounds that are blockers versus substrates of EAAT2 and, secondly, the pharmacological differences between EAAT1 and EAAT2.
Zinc ions (Zn2+) are stored in synaptic vesicles with glutamate in a number of regions of the brain. When released into the synapse, Zn2+ modulates the activity of various receptors and ion channels. Excitatory amino acid transporters (EAATs) maintain extracellular glutamate concentrations below toxic levels and regulate the kinetics of glutamate receptor activation. We have investigated the actions of Zn2+ on two of the most abundant human excitatory amino acid transporters, EAAT1 and EAAT2. Zn2+ is a noncompetitive, partial inhibitor of glutamate transport by EAAT1 with an IC50 value of 9.9 +/- 2.3 microM and has no effect on glutamate transport by EAAT2 at concentrations up to 300 microM. Glutamate and aspartate transport by EAAT1 are associated with an uncoupled chloride conductance, but Zn2+ selectively inhibits transport and increases the relative chloride flux through the transporter. We have investigated the molecular basis for differential inhibition of EAAT1 and EAAT2 by Zn2+ using site-directed mutagenesis and demonstrate that histidine residues of EAAT1 at positions 146 and 156 form part of the Zn2+ binding site. EAAT2 contains a histidine residue at the position corresponding to histidine 146 of EAAT1, but at the position corresponding to histidine 156 of EAAT1, EAAT2 has a glycine residue. Mutation of this glycine residue in EAAT2 to histidine generates a Zn2+ sensitive transporter, further confirming the role of this residue in conferring differential Zn2+ sensitivity.
We report the synthesis of a series of 3-carboxy-, 3-(carboxymethyl)-, 3-(omega-phosphonoalkyl)-1-aminocyclobutane-1-carboxylic acids for evaluation as agonists or antagonists of neurotransmission at excitatory amino acid receptors, particularly N-methyl-D-aspartic acid (NMDA) receptors. The compounds were evaluated as agonists on their ability to depolarize the rat brain cortical wedge preparation or as antagonist of the actions of the selective agonists NMDA, quisqualic acid, and kainic acid. The chain-elongated glutamate derivatives with potential antagonist activity proved to be weak and frequently nonselective antagonists in this assay. The most noteworthy result was that trans isomer 7b was a very potent agonist, approximately 20 times more active than NMDA at NMDA receptors, while the cis isomer was 1/3 as potent as NMDA.
In the central nervous system, glycine is a coagonist with glutamate at the N-methyl-D-aspartate subtype of ionotropic glutamate receptors. The GLYT1b subtype of glycine transporters is expressed in similar regions of the brain as the excitatory N-methyl-D-aspartate receptors and has been postulated to regulate glycine concentrations within excitatory synapses. We have expressed GLYT1b in Xenopus laevis oocytes and used electrophysiological techniques to investigate the pH regulation of glycine transporter function. We found that H ϩ inhibits glycine transport by a noncompetitive mechanism, with half-maximal inhibition occurring at concentrations found in both physiological and pathological conditions. Charge-to-flux experiments revealed that the decreased current measured corresponds to a decreased influx of [ 3 H]glycine and that the proton inhibition of GLYT1b does not alter the coupling ratio of transport. The membrane potential does not affect proton inhibition of transport, suggesting that the site of action on GLYT1b is not within the electric field of the membrane. Mutation of histidine 421 to an alanine residue, in the fourth extracellular loop of GLYT1b, renders the transporter insensitive to regulation by pH, but does not seem to alter the kinetics of glycine transport. These results suggests that histidine 421 is responsible for mediating the inhibitory actions of protons. Proton modulation of GLYT1b may be an important factor in determining the dynamics of excitatory neurotransmission.
Glutamate transporters serve the important function of mediating removal of glutamate released at excitatory synapses and maintaining extracellular concentrations below excitotoxic levels. Excitatory amino acid transporter subtypes EAAT1 and EAAT2 have a high degree of sequence homology and similar predicted topology and yet display a number of functional differences. Several recombinant chimeric transporters were generated to identify domains that contribute to functional differences between EAAT1 and EAAT2. Wild-type transporters and chimeric transporters were expressed in Xenopus laevis oocytes, and electrogenic transport was studied under voltage clamp conditions. The differential sensitivity of EAAT1 and EAAT2 to transport blockers, kainate, threo-3-methylglutamate, and (2S,4R)-4-methylglutamate as well as L-serine-O-sulfate transport and chloride permeability were employed to characterize chimeric transporters. One particular region, transmembrane domains 9 and 10, plays an important role in defining these functional differences. The intracellular carboxyl-terminal region may also play a minor role in conferring an effect on chloride permeability. This study provides important insight into the identification of functional domains that determine differences among glutamate transporter subtypes.L-Glutamate transport in the central nervous system and also in peripheral organs is mediated by a family of structurally related membrane proteins. In the central nervous system, glutamate transporters play an important role by mediating removal of glutamate released at excitatory synapses and also influencing the kinetics of glutamate receptor activation (1, 2). Complementary DNAs encoding five different glutamate transporters have been identified (3-7). The human clones have been named Excitatory Amino Acid Transporters 1-5 (EAAT1-5) (6-8). The recent cloning and expression of recombinant glutamate transporter proteins in heterologous expression systems allow a number of questions concerning the molecular basis for transporter function to be addressed. In particular, an important aspect of such studies is the identification of domains involved in substrate recognition and substrate translocation through the membrane. In this study we have constructed a series of chimeric glutamate transporters, using the EAAT1 and EAAT2 subtypes, and exploited the pharmacological and electrophysiological differences between the two subtypes to map functional domains of these proteins.To make meaningful predictions about the functional role of various domains, an understanding of the structure of the transporters is particularly useful. The predicted amino acid sequences of EAAT1 and EAAT2 are 65% identical, and if conservative substitutions are allowed the degree of relatedness is increased to 80% (8). These two proteins are likely to form very similar structures and therefore are good candidates for the generation of functional chimeras. Through the use of hydrophobicity analysis of the amino acid sequences it has been predicted t...
1 Expression of the recombinant human excitatory amino aid transporters, EAAT1 and EAAT2, in Xenopus laevis oocytes allows electrogenic transport to be studied under voltage clamp conditions. 2 We have investigated the transport of the pharmacological substrate, L-serine-O-sulphate transport by EAAT1 and EAAT2. The EC 50 values for L-serine-O-sulphate transport by EAAT2 showed a steep voltage-dependence, increasing from 152+11 mM at 7100 mV to 1930+160 mM at 0 mV. In contrast to EAAT2, EC 50 values for L-serine-O-sulphate transport by EAAT1 were relatively constant over the membrane potential range of 7100 mV to 0 mV. The EC 50 values for L-glutamate and D-aspartate transport, by EAAT2, were also relatively constant over this membrane potential range. 3 Chloride ions modulated the voltage-dependent changes in EC 50 values for transport by EAAT2. This eect was most apparent for L-serine-O-sulphate transport, and to a lesser extent for L-glutamate and not at all for D-aspartate transport by EAAT2. 4 Extracellular sodium and proton concentrations also modulated the voltage-dependence of L-serine-O-sulphate EC 50 values for EAAT2. 5 We speculate that these dierent properties of L-serine-O-sulphate transport by EAAT2 compared to other substrates may be due to the much stronger acidity of the sulphate group of L-serine-O-sulphate compared to carboxyl groups of L-glutamate or D-aspartate. 6 These results highlight some of the dierences in the way dierent glutamate transporter subtypes transport substrates. This may be used to understand further the transport process and develop subtype selective inhibitors of glutamate transport.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.